Global Age-Related Macular Degeneration (AMD) AI Screening System Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Page: 103

Published Date: 22 Apr 2024

Category: Service & Software

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Age-related macular degeneration (AMD) represents one of leading cause of visual impairment in developed countries and a major target for AI-based approaches. The analysis of AMD data is mainly based on optical coherence tomography(OCT) images; thus, image segmentation is a fundamental step for accurately recognizing retinal structures. Many unsupervised AI-based segmentation algorithms have been developed, providing very high performance in detecting   retinal features. These algorithms are useful not only for assessing the   integrity of retinal structures, but also for localizing and quantifying   retinal fluids during follow-up.

According to our (Global Info Research) latest study, the global Age-Related Macular Degeneration (AMD) AI Screening System market size was valued at US$ 46.5 million in 2023 and is forecast to a readjusted size of USD 2985 million by 2030 with a CAGR of 79.9% during review period.

The age-related macular degeneration (AMD) market trends are shaping the growth of the market. For instance rise in the adoption of age-related macular degeneration drugs (AMD) among the geriatric population suffering from age-related macular degeneration (AMD) drives the growth of the age-related macular degeneration (AMD) market size. For instance, according to the 2022 factsheet of World Health Organization, by 2030, 1 in 6 people in the world is projected to be aged 60 years or over, indicating a potential increase in the age-related macular degeneration (AMD) market size.

This report is a detailed and comprehensive analysis for global Age-Related Macular Degeneration (AMD) AI Screening System market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Age-Related Macular Degeneration (AMD) AI Screening System market size and forecasts, in consumption value ($ Million), 2019-2030
Global Age-Related Macular Degeneration (AMD) AI Screening System market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Age-Related Macular Degeneration (AMD) AI Screening System market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Age-Related Macular Degeneration (AMD) AI Screening System market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Age-Related Macular Degeneration (AMD) AI Screening System
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Age-Related Macular Degeneration (AMD) AI Screening System market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Airdoc Technology, Digital Diagnostics, Eyenuk, RetinaLyze System, Optomed, Sibionics Technology, Aeye Health, VUNO, Medimaging Integrated Solution, EyRIS (SELENA+), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market segmentation
Age-Related Macular Degeneration (AMD) AI Screening System market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segmentation
Age-Related Macular Degeneration (AMD) AI Screening System market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Hardware
    Software

Market segment by Application
    Medical Institutions
    Great Health Scene

Market segment by players, this report covers
    Airdoc Technology
    Digital Diagnostics
    Eyenuk
    RetinaLyze System
    Optomed
    Sibionics Technology
    Aeye Health
    VUNO
    Medimaging Integrated Solution
    EyRIS (SELENA+)
    Vistel
    RETINA-AI Health
    Acer Medical

Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Age-Related Macular Degeneration (AMD) AI Screening System product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Age-Related Macular Degeneration (AMD) AI Screening System, with revenue, gross margin, and global market share of Age-Related Macular Degeneration (AMD) AI Screening System from 2019 to 2024.
Chapter 3, the Age-Related Macular Degeneration (AMD) AI Screening System competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Age-Related Macular Degeneration (AMD) AI Screening System market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Age-Related Macular Degeneration (AMD) AI Screening System.
Chapter 13, to describe Age-Related Macular Degeneration (AMD) AI Screening System research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Classification of Age-Related Macular Degeneration (AMD) AI Screening System by Type
        1.3.1 Overview: Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Type in 2023
        1.3.3 Hardware
        1.3.4 Software
    1.4 Global Age-Related Macular Degeneration (AMD) AI Screening System Market by Application
        1.4.1 Overview: Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Medical Institutions
        1.4.3 Great Health Scene
    1.5 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size & Forecast
    1.6 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast by Region
        1.6.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region: 2019 VS 2023 VS 2030
        1.6.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region, (2019-2030)
        1.6.3 North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Prospect (2019-2030)
        1.6.4 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Prospect (2019-2030)
        1.6.5 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Prospect (2019-2030)
        1.6.6 South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Prospect (2019-2030)
        1.6.7 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Prospect (2019-2030)

2 Company Profiles
    2.1 Airdoc Technology
        2.1.1 Airdoc Technology Details
        2.1.2 Airdoc Technology Major Business
        2.1.3 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
        2.1.4 Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Airdoc Technology Recent Developments and Future Plans
    2.2 Digital Diagnostics
        2.2.1 Digital Diagnostics Details
        2.2.2 Digital Diagnostics Major Business
        2.2.3 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
        2.2.4 Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Digital Diagnostics Recent Developments and Future Plans
    2.3 Eyenuk
        2.3.1 Eyenuk Details
        2.3.2 Eyenuk Major Business
        2.3.3 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
        2.3.4 Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Eyenuk Recent Developments and Future Plans
    2.4 RetinaLyze System
        2.4.1 RetinaLyze System Details
        2.4.2 RetinaLyze System Major Business
        2.4.3 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
        2.4.4 RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 RetinaLyze System Recent Developments and Future Plans
    2.5 Optomed
        2.5.1 Optomed Details
        2.5.2 Optomed Major Business
        2.5.3 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
        2.5.4 Optomed Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Optomed Recent Developments and Future Plans
    2.6 Sibionics Technology
        2.6.1 Sibionics Technology Details
        2.6.2 Sibionics Technology Major Business
        2.6.3 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
        2.6.4 Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Sibionics Technology Recent Developments and Future Plans
    2.7 Aeye Health
        2.7.1 Aeye Health Details
        2.7.2 Aeye Health Major Business
        2.7.3 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
        2.7.4 Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        2.7.5 Aeye Health Recent Developments and Future Plans
    2.8 VUNO
        2.8.1 VUNO Details
        2.8.2 VUNO Major Business
        2.8.3 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
        2.8.4 VUNO Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        2.8.5 VUNO Recent Developments and Future Plans
    2.9 Medimaging Integrated Solution
        2.9.1 Medimaging Integrated Solution Details
        2.9.2 Medimaging Integrated Solution Major Business
        2.9.3 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
        2.9.4 Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        2.9.5 Medimaging Integrated Solution Recent Developments and Future Plans
    2.10 EyRIS (SELENA+)
        2.10.1 EyRIS (SELENA+) Details
        2.10.2 EyRIS (SELENA+) Major Business
        2.10.3 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
        2.10.4 EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        2.10.5 EyRIS (SELENA+) Recent Developments and Future Plans
    2.11 Vistel
        2.11.1 Vistel Details
        2.11.2 Vistel Major Business
        2.11.3 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
        2.11.4 Vistel Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        2.11.5 Vistel Recent Developments and Future Plans
    2.12 RETINA-AI Health
        2.12.1 RETINA-AI Health Details
        2.12.2 RETINA-AI Health Major Business
        2.12.3 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
        2.12.4 RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        2.12.5 RETINA-AI Health Recent Developments and Future Plans
    2.13 Acer Medical
        2.13.1 Acer Medical Details
        2.13.2 Acer Medical Major Business
        2.13.3 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
        2.13.4 Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Revenue, Gross Margin and Market Share (2019-2024)
        2.13.5 Acer Medical Recent Developments and Future Plans

3 Market Competition, by Players
    3.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue and Share by Players (2019-2024)
    3.2 Market Share Analysis (2023)
        3.2.1 Market Share of Age-Related Macular Degeneration (AMD) AI Screening System by Company Revenue
        3.2.2 Top 3 Age-Related Macular Degeneration (AMD) AI Screening System Players Market Share in 2023
        3.2.3 Top 6 Age-Related Macular Degeneration (AMD) AI Screening System Players Market Share in 2023
    3.3 Age-Related Macular Degeneration (AMD) AI Screening System Market: Overall Company Footprint Analysis
        3.3.1 Age-Related Macular Degeneration (AMD) AI Screening System Market: Region Footprint
        3.3.2 Age-Related Macular Degeneration (AMD) AI Screening System Market: Company Product Type Footprint
        3.3.3 Age-Related Macular Degeneration (AMD) AI Screening System Market: Company Product Application Footprint
    3.4 New Market Entrants and Barriers to Market Entry
    3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type
    4.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value and Market Share by Type (2019-2024)
    4.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Forecast by Type (2025-2030)

5 Market Size Segment by Application
    5.1 Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Application (2019-2024)
    5.2 Global Age-Related Macular Degeneration (AMD) AI Screening System Market Forecast by Application (2025-2030)

6 North America
    6.1 North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2030)
    6.2 North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Application (2019-2030)
    6.3 North America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
        6.3.1 North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2019-2030)
        6.3.2 United States Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        6.3.3 Canada Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        6.3.4 Mexico Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)

7 Europe
    7.1 Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2030)
    7.2 Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2030)
    7.3 Europe Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
        7.3.1 Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2019-2030)
        7.3.2 Germany Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        7.3.3 France Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        7.3.4 United Kingdom Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        7.3.5 Russia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        7.3.6 Italy Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)

8 Asia-Pacific
    8.1 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2030)
    8.2 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2030)
    8.3 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Region
        8.3.1 Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Region (2019-2030)
        8.3.2 China Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        8.3.3 Japan Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        8.3.4 South Korea Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        8.3.5 India Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        8.3.6 Southeast Asia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        8.3.7 Australia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)

9 South America
    9.1 South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2030)
    9.2 South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2030)
    9.3 South America Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
        9.3.1 South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2019-2030)
        9.3.2 Brazil Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        9.3.3 Argentina Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)

10 Middle East & Africa
    10.1 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2030)
    10.2 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2030)
    10.3 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Market Size by Country
        10.3.1 Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2019-2030)
        10.3.2 Turkey Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        10.3.3 Saudi Arabia Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)
        10.3.4 UAE Age-Related Macular Degeneration (AMD) AI Screening System Market Size and Forecast (2019-2030)

11 Market Dynamics
    11.1 Age-Related Macular Degeneration (AMD) AI Screening System Market Drivers
    11.2 Age-Related Macular Degeneration (AMD) AI Screening System Market Restraints
    11.3 Age-Related Macular Degeneration (AMD) AI Screening System Trends Analysis
    11.4 Porters Five Forces Analysis
        11.4.1 Threat of New Entrants
        11.4.2 Bargaining Power of Suppliers
        11.4.3 Bargaining Power of Buyers
        11.4.4 Threat of Substitutes
        11.4.5 Competitive Rivalry

12 Industry Chain Analysis
    12.1 Age-Related Macular Degeneration (AMD) AI Screening System Industry Chain
    12.2 Age-Related Macular Degeneration (AMD) AI Screening System Upstream Analysis
    12.3 Age-Related Macular Degeneration (AMD) AI Screening System Midstream Analysis
    12.4 Age-Related Macular Degeneration (AMD) AI Screening System Downstream Analysis

13 Research Findings and Conclusion

14 Appendix
    14.1 Methodology
    14.2 Research Process and Data Source
    14.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Region (2019-2024) & (USD Million)
 Table 4. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Region (2025-2030) & (USD Million)
 Table 5. Airdoc Technology Company Information, Head Office, and Major Competitors
 Table 6. Airdoc Technology Major Business
 Table 7. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
 Table 8. Airdoc Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 9. Airdoc Technology Recent Developments and Future Plans
 Table 10. Digital Diagnostics Company Information, Head Office, and Major Competitors
 Table 11. Digital Diagnostics Major Business
 Table 12. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
 Table 13. Digital Diagnostics Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 14. Digital Diagnostics Recent Developments and Future Plans
 Table 15. Eyenuk Company Information, Head Office, and Major Competitors
 Table 16. Eyenuk Major Business
 Table 17. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
 Table 18. Eyenuk Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 19. RetinaLyze System Company Information, Head Office, and Major Competitors
 Table 20. RetinaLyze System Major Business
 Table 21. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
 Table 22. RetinaLyze System Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 23. RetinaLyze System Recent Developments and Future Plans
 Table 24. Optomed Company Information, Head Office, and Major Competitors
 Table 25. Optomed Major Business
 Table 26. Optomed Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
 Table 27. Optomed Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 28. Optomed Recent Developments and Future Plans
 Table 29. Sibionics Technology Company Information, Head Office, and Major Competitors
 Table 30. Sibionics Technology Major Business
 Table 31. Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
 Table 32. Sibionics Technology Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 33. Sibionics Technology Recent Developments and Future Plans
 Table 34. Aeye Health Company Information, Head Office, and Major Competitors
 Table 35. Aeye Health Major Business
 Table 36. Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
 Table 37. Aeye Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 38. Aeye Health Recent Developments and Future Plans
 Table 39. VUNO Company Information, Head Office, and Major Competitors
 Table 40. VUNO Major Business
 Table 41. VUNO Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
 Table 42. VUNO Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 43. VUNO Recent Developments and Future Plans
 Table 44. Medimaging Integrated Solution Company Information, Head Office, and Major Competitors
 Table 45. Medimaging Integrated Solution Major Business
 Table 46. Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
 Table 47. Medimaging Integrated Solution Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 48. Medimaging Integrated Solution Recent Developments and Future Plans
 Table 49. EyRIS (SELENA+) Company Information, Head Office, and Major Competitors
 Table 50. EyRIS (SELENA+) Major Business
 Table 51. EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
 Table 52. EyRIS (SELENA+) Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 53. EyRIS (SELENA+) Recent Developments and Future Plans
 Table 54. Vistel Company Information, Head Office, and Major Competitors
 Table 55. Vistel Major Business
 Table 56. Vistel Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
 Table 57. Vistel Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 58. Vistel Recent Developments and Future Plans
 Table 59. RETINA-AI Health Company Information, Head Office, and Major Competitors
 Table 60. RETINA-AI Health Major Business
 Table 61. RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
 Table 62. RETINA-AI Health Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 63. RETINA-AI Health Recent Developments and Future Plans
 Table 64. Acer Medical Company Information, Head Office, and Major Competitors
 Table 65. Acer Medical Major Business
 Table 66. Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Product and Solutions
 Table 67. Acer Medical Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 68. Acer Medical Recent Developments and Future Plans
 Table 69. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue (USD Million) by Players (2019-2024)
 Table 70. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Share by Players (2019-2024)
 Table 71. Breakdown of Age-Related Macular Degeneration (AMD) AI Screening System by Company Type (Tier 1, Tier 2, and Tier 3)
 Table 72. Market Position of Players in Age-Related Macular Degeneration (AMD) AI Screening System, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 73. Head Office of Key Age-Related Macular Degeneration (AMD) AI Screening System Players
 Table 74. Age-Related Macular Degeneration (AMD) AI Screening System Market: Company Product Type Footprint
 Table 75. Age-Related Macular Degeneration (AMD) AI Screening System Market: Company Product Application Footprint
 Table 76. Age-Related Macular Degeneration (AMD) AI Screening System New Market Entrants and Barriers to Market Entry
 Table 77. Age-Related Macular Degeneration (AMD) AI Screening System Mergers, Acquisition, Agreements, and Collaborations
 Table 78. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (USD Million) by Type (2019-2024)
 Table 79. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Share by Type (2019-2024)
 Table 80. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Forecast by Type (2025-2030)
 Table 81. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2024)
 Table 82. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Forecast by Application (2025-2030)
 Table 83. North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2024) & (USD Million)
 Table 84. North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2025-2030) & (USD Million)
 Table 85. North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2024) & (USD Million)
 Table 86. North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2025-2030) & (USD Million)
 Table 87. North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2019-2024) & (USD Million)
 Table 88. North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2025-2030) & (USD Million)
 Table 89. Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2024) & (USD Million)
 Table 90. Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2025-2030) & (USD Million)
 Table 91. Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2024) & (USD Million)
 Table 92. Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2025-2030) & (USD Million)
 Table 93. Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2019-2024) & (USD Million)
 Table 94. Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2025-2030) & (USD Million)
 Table 95. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2024) & (USD Million)
 Table 96. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2025-2030) & (USD Million)
 Table 97. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2024) & (USD Million)
 Table 98. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2025-2030) & (USD Million)
 Table 99. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Region (2019-2024) & (USD Million)
 Table 100. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Region (2025-2030) & (USD Million)
 Table 101. South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2024) & (USD Million)
 Table 102. South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2025-2030) & (USD Million)
 Table 103. South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2024) & (USD Million)
 Table 104. South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2025-2030) & (USD Million)
 Table 105. South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2019-2024) & (USD Million)
 Table 106. South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2025-2030) & (USD Million)
 Table 107. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2019-2024) & (USD Million)
 Table 108. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type (2025-2030) & (USD Million)
 Table 109. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2019-2024) & (USD Million)
 Table 110. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application (2025-2030) & (USD Million)
 Table 111. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2019-2024) & (USD Million)
 Table 112. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Country (2025-2030) & (USD Million)
 Table 113. Global Key Players of Age-Related Macular Degeneration (AMD) AI Screening System Upstream (Raw Materials)
 Table 114. Global Age-Related Macular Degeneration (AMD) AI Screening System Typical Customers


List of Figures
 Figure 1. Age-Related Macular Degeneration (AMD) AI Screening System Picture
 Figure 2. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Type in 2023
 Figure 4. Hardware
 Figure 5. Software
 Figure 6. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Application in 2023
 Figure 8. Medical Institutions Picture
 Figure 9. Great Health Scene Picture
 Figure 10. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 11. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 12. Global Market Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (USD Million) Comparison by Region (2019 VS 2023 VS 2030)
 Figure 13. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Region (2019-2030)
 Figure 14. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Region in 2023
 Figure 15. North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 16. Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 17. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 18. South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 19. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 20. Company Three Recent Developments and Future Plans
 Figure 21. Global Age-Related Macular Degeneration (AMD) AI Screening System Revenue Share by Players in 2023
 Figure 22. Age-Related Macular Degeneration (AMD) AI Screening System Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2023
 Figure 23. Market Share of Age-Related Macular Degeneration (AMD) AI Screening System by Player Revenue in 2023
 Figure 24. Top 3 Age-Related Macular Degeneration (AMD) AI Screening System Players Market Share in 2023
 Figure 25. Top 6 Age-Related Macular Degeneration (AMD) AI Screening System Players Market Share in 2023
 Figure 26. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Share by Type (2019-2024)
 Figure 27. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share Forecast by Type (2025-2030)
 Figure 28. Global Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Share by Application (2019-2024)
 Figure 29. Global Age-Related Macular Degeneration (AMD) AI Screening System Market Share Forecast by Application (2025-2030)
 Figure 30. North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Type (2019-2030)
 Figure 31. North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Application (2019-2030)
 Figure 32. North America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Country (2019-2030)
 Figure 33. United States Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 34. Canada Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 35. Mexico Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 36. Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Type (2019-2030)
 Figure 37. Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Application (2019-2030)
 Figure 38. Europe Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Country (2019-2030)
 Figure 39. Germany Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 40. France Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 41. United Kingdom Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 42. Russia Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 43. Italy Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 44. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Type (2019-2030)
 Figure 45. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Application (2019-2030)
 Figure 46. Asia-Pacific Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Region (2019-2030)
 Figure 47. China Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 48. Japan Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 49. South Korea Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 50. India Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 51. Southeast Asia Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 52. Australia Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 53. South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Type (2019-2030)
 Figure 54. South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Application (2019-2030)
 Figure 55. South America Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Country (2019-2030)
 Figure 56. Brazil Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 57. Argentina Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 58. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Type (2019-2030)
 Figure 59. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Application (2019-2030)
 Figure 60. Middle East & Africa Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value Market Share by Country (2019-2030)
 Figure 61. Turkey Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 62. Saudi Arabia Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 63. UAE Age-Related Macular Degeneration (AMD) AI Screening System Consumption Value (2019-2030) & (USD Million)
 Figure 64. Age-Related Macular Degeneration (AMD) AI Screening System Market Drivers
 Figure 65. Age-Related Macular Degeneration (AMD) AI Screening System Market Restraints
 Figure 66. Age-Related Macular Degeneration (AMD) AI Screening System Market Trends
 Figure 67. Porters Five Forces Analysis
 Figure 68. Age-Related Macular Degeneration (AMD) AI Screening System Industrial Chain
 Figure 69. Methodology
 Figure 70. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Airdoc Technology
Digital Diagnostics
Eyenuk
RetinaLyze System
Optomed
Sibionics Technology
Aeye Health
VUNO
Medimaging Integrated Solution
EyRIS (SELENA+)
Vistel
RETINA-AI Health
Acer Medical

Related Reports

Global Age-Related Macular Degeneration (AMD) AI Screening System Supply, Demand and Key Producers, 2024-2030

Global Age-Related Macular Degeneration (AMD) AI Screening System Supply, Demand and Key Producers, 2024-2030

date 22 Apr 2024

date Service & Software

Age-related macular degeneration (AMD) represents one of leading cause of visual impairment in developed countries and a major target for AI-based approaches. The analysis of AMD data is mainly based on optical coherence tomography(OCT) images; thus, image segmentation is a fundamental step for accurately recognizing retinal structures. Many unsupervised AI-based segmentation algorithms have been developed, providing very high performance in detecting retinal features. These algorithms are useful not only for assessing the integrity of retinal structures, but also for localizing and quantifying retinal fluids during follow-up.

Product Tags

soil fertility

Image High Dynamic

Building Energy Modeling

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>